Launch of antihypertensive drug Ramiril tablets (Ramipril 5mg)

 

 

 


Ramiryl Tab. is an antihypertensive drug containing 5 mg of Ramipril, an ACEI, and is indicated for essential hypertension and heart failure after myocardial infarction.
It has excellent blood pressure lowering power due to its high selectivity and affinity for ACE (Angiotensin Converting Enzyme), so it can be used to treat mild to moderate hypertension. It is not only effective in lowering the mortality rate of patients with heart failure after myocardial infarction, but also has a high affinity for lipids and a long half-life compared to other ACEIs, effectively inhibiting ACE in local tissues.
It also has the feature of reducing adverse reactions and increasing treatment effectiveness when prescribed in combination with Felodipine tablets and Simvastatin tablets.
 
⊙ Ingredients/Content
   Ramipril 5mg

⊙ Efficacy/Effectiveness
Essential hypertension, heart failure after myocardial infarction

⊙ Usage/Dosage
1. Essential hypertension
Initial dose: 2.5mg once a day, increase to 5mg once a day if necessary, maximum dose: 10mg per day,
Increase dose every 2-3 weeks
2. Heart failure after myocardial infarction
Initial dose 2.5mg twice a day, target dose 5mg twice a day
(If you have symptoms of low blood pressure, take 1.25 mg twice a day)
  
⊙ Appearance: Light red oblong tablet

⊙ Storage method: Airtight container, stored at room temperature (1~30°C)

⊙ Insurance price: 645 won/T

⊙ Insurance code: A17603931

⊙ Packaging unit: 100 tablets